PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 11, 2026Pediatric Emergency Care0 citations

Risk Factors for Invasive Infection in Febrile Oncology Patients Related to Cancer Type

View Full Paper
BGBorja GómezOQOriol QuintanaMMMirian Soriano Moreno

Key Points

  • The aim is to identify clinical and laboratory risk factors for invasive infection in febrile oncology patients based on cancer type.
  • Prospective observational study conducted from 2016 to 2023.
  • Included febrile oncology patients in a Pediatric Emergency Department.
  • Risk factors were analyzed separately for hematologic cancers and solid tumors.
  • Invasive infection was defined microbiologically and clinically, with specific criteria for hematological cancers.
  • 471 episodes were included: 306 with hematologic cancers and 165 with solid tumors.
  • Invasive infections occurred in 69 cases (14.6%).
  • Higher rate of infections in high-risk hematologic cancers (23.2%) compared to solid tumors (10.9%) and low-risk hematologic cancers (5.4%).
  • High-risk cancer type and elevated procalcitonin predicted invasive infection in hematologic cancers (OR: 6.006 and OR: 1.668, respectively).
  • Age was identified as an independent risk factor in patients with solid tumors (OR: 1.145).

Abstract

Objective: To identify clinical and laboratory risk factors for invasive infection in febrile oncology patients seen in the Pediatric Emergency Department, depending on the type of cancer. Methods: We conducted a prospective observational study of febrile oncology patients seen between 2016 and 2023 at the Pediatric Emergency Department of a tertiary teaching hospital. Invasive infection was defined microbiologically (isolation of a bacterial pathogen in sterile fluid or a commensal bacterial species in 2 different blood cultures) or clinically (death, meeting Phoenix criteria for sepsis, receiving inotropic support, or developing acute complications or sequelae). We performed separate multivariate analyses for hematologic cancers and solid tumors. Hematologic cancers were further classified considering the myelotoxicity of the chemotherapy received. We classified the following as high-risk hematologic cancers: acute lymphoblastic leukemia and non-Hodgkin lymphoma in the induction, reinduction, or consolidation phase or relapse, and acute myeloid leukemia in any phase Results: We included 471 episodes: 306 hematologic cancers and 165 solid tumors. The median age was 4 years (interquartile range: 2 to 10) and the median duration of fever was 2 hours (interquartile range: 1 to 3). Invasive infections were diagnosed in 69 cases (14.6%). The rate was higher among patients with high-risk hematologic cancers (n=45, 23.2%), than among those with solid tumors (n=18, 10.9%; P =0.002) or with low-risk hematologic cancers (n=6, 5.4%; P <0.001). Among patients with hematological cancers, presenting a high-risk cancer (OR: 6.006; 95% CI: 2.459-18.200) and elevated procalcitonin levels (OR: 1.668; 95% CI: 1.205-2.571) were predictors of invasive infection AUC for the model: 0.718 (95% CI: 0.640-0.795). Only age (OR: 1.145; 95% CI: 1.036-1.267) was found to be an independent risk factor in patients with solid tumors. Conclusions: In patients with hematologic cancers and very recent onset fever, the type of cancer and procalcitonin level are useful for predicting the risk of invasive infection.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gómez et al. (2026) studied this question.

synapsesocial.com/papers/698c1bef267fb587c655deabhttps://doi.org/10.1097/pec.0000000000003571
Ask AI
Helpful
Bookmark
Share
View Full Paper